Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) Depreciation & Amortization (IS) (2016 - 2019)

Xtant Medical Holdings (XTNT) has disclosed Depreciation & Amortization (IS) for 10 consecutive years, with $137000.0 as the latest value for Q3 2019.

  • On a quarterly basis, Depreciation & Amortization (IS) fell 86.69% to $137000.0 in Q3 2019 year-over-year; TTM through Sep 2019 was $1.5 million, a 66.64% decrease, with the full-year FY2018 number at $4.1 million, down 24.92% from a year prior.
  • Depreciation & Amortization (IS) was $137000.0 for Q3 2019 at Xtant Medical Holdings, down from $146000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $2.1 million in Q4 2015 to a low of $100663.0 in Q2 2015.
  • A 5-year average of $989767.5 and a median of $1.2 million in 2016 define the central range for Depreciation & Amortization (IS).
  • Peak YoY movement for Depreciation & Amortization (IS): soared 3606.51% in 2015, then plummeted 86.69% in 2019.
  • Xtant Medical Holdings' Depreciation & Amortization (IS) stood at $2.1 million in 2015, then plummeted by 39.11% to $1.3 million in 2016, then increased by 10.4% to $1.4 million in 2017, then decreased by 24.37% to $1.0 million in 2018, then crashed by 86.88% to $137000.0 in 2019.
  • Per Business Quant, the three most recent readings for XTNT's Depreciation & Amortization (IS) are $137000.0 (Q3 2019), $146000.0 (Q2 2019), and $159000.0 (Q1 2019).